AAV Transduction of MSCs is Enhanced by Genetic Engineering Medium

被引：0
|
作者：
Doolin, Mary [1 ]
Willstaedt, Therese [1 ]
Boychyn, Michael [1 ]
Rowley, Jon [1 ]
机构：
[1] RoosterBio, Frederick, MD USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
453
引用
收藏
页码：233 / 234
页数：2
相关论文
共 50 条
  • [21] Elucidating the mechanism behind enhanced retinal transduction of an AAV2 variant
    Woodard, Kenton
    Samulski, Richard
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [22] Genetic Engineering of AAV Capsid Gene for Gene Therapy Application
    Liu, Yunbo
    Zhang, Xu
    Yang, Lin
    CURRENT GENE THERAPY, 2020, 20 (05) : 321 - 332
  • [23] Novel AAV Capsids Display Expansive Transduction and Enhanced Potency in Subretinally Injected Mice
    Crosson, Sean M.
    Choudhury, Shreyasi
    Mellen, Russell
    Makal, Victoria
    Fajardo, Diego
    Peterson, James J.
    Zhang, Hangning
    Di Pasquale, Giovanni
    Chiorini, Jay A.
    Boye, Sanford L.
    Boye, Shannon E.
    MOLECULAR THERAPY, 2019, 27 (04) : 430 - 431
  • [24] Enhanced Liver Transduction With Novel AAV Resistant To Pre-Existing Immunity in Humans
    Khaychuk, Vadim
    Zinn, Eric
    Plovie, Eva
    Sarkar, Debalina
    Carvalho, Livia
    Shah, Samiksha
    Vandenberghe, Luk H.
    MOLECULAR THERAPY, 2014, 22 : S225 - S225
  • [25] Optimized vector purification and delivery methods to achieve enhanced liver transduction by AAV vectors
    Ayuso, Eduard
    Montane, Joel
    Mingozzi, Federico
    Anguela, Xavier M.
    Leon, Xavier
    Mann, Christopher
    Callejas, David
    Jimenez, Veronica
    Tafuro, Sabrina
    Andaluz, Anna
    Garcia, Felix
    Zhou, Shangzhen
    Wright, Fraiser
    High, Katherine A.
    Bosch, Fatima
    HUMAN GENE THERAPY, 2008, 19 (10) : 1118 - 1119
  • [26] Optimizing IdeS treatment regimen for enhanced AAV transduction in individuals with pre-existing anti-AAV neutralizing antibodies
    Ros-Ganan, I.
    Hommel, M.
    Trigueros-Motos, L.
    Tamarit, B.
    Rodriguez-Garcia, E.
    Salas, D.
    Douar, A.
    Combal, J. P.
    Benichou, B.
    Ferrer, V.
    Gonzalez-Aseguinolaza, G.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A29 - A29
  • [27] Efficient In Vivo Genetic Engineering of Lymphocytes after Systemic AAV Delivery
    Breuer, Cort B.
    Natasan, Jeya-Shree
    Volak, Adrienn
    Hanlon, Killian
    Riffe, Jackson C.
    Meliani, Amine
    Mingozzi, Federico
    Kleinstiver, Benjamin P.
    Moon, James J.
    Maguire, Casey A.
    MOLECULAR THERAPY, 2019, 27 (04) : 354 - 354
  • [28] The calcification potential of human MSCs can be enhanced by interleukin-1β in osteogenic medium
    Loebel, Claudia
    Czekanska, Ewa M.
    Staudacher, Judith
    Salzmann, Gian
    Richards, R. Geoff
    Alini, Mauro
    Stoddart, Martin J.
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2017, 11 (02) : 564 - 571
  • [29] Development of self-complimenentary AAV vectors with markedly enhanced hepatocyte transduction efficiency.
    Petras, O
    Liu, T
    Lyandres, J
    Davern, TJ
    HEPATOLOGY, 2002, 36 (04) : 245A - 245A
  • [30] Selection of Engineered AAV Capsids with Enhanced Incorporation into Extracellular Vesicles and Stable Liver Transduction In Vivo
    Cheng, Ming
    Patel, Nikita
    Nammour, Josette
    Ng, Carrie
    Hanlon, Killian S.
    Maguire, Casey A.
    MOLECULAR THERAPY, 2022, 30 (04) : 388 - 388
12345